A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer

Published:2019-09-02 Issue:1 Volume:14 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Kainuma Takuro,Kawakami Shogo,Tsumura Hideyasu,Satoh Takefumi,Tabata Ken-ichi,Iwamura Masatsugu,Hayakawa Kazushige,Ishiyama Hiromichi

Funder

Japanse Foundation for Multidisciplinary Treatment of Cancer

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-019-1369-y.pdf

Reference18 articles.

1. Alongi F, Mazzola R, Fiorentino A, et al. Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer. Strahlenther Onkol. 2019;195:113.

2. Katz A. Stereotactic body radiotherapy for low-risk prostate Cancer: a ten-year analysis. Cureus. 2017;9:e1668.

3. De Bari B, Arcangeli S, Ciardo D, et al. Extreme hypofractionation for early prostate cancer: biology meets technology. Cancer Treat Rev. 2016;50:48.

4. Demanes DJ, Martinez AA, Ghilezan M, et al. High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2011;81:1286.

5. Ghadjar P, Keller T, Rentsch CA, et al. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. Brachytherapy. 2009;8:45.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. In Curative Stereotactic Body Radiation Therapy for Prostate Cancer, There Is a High Possibility That 45 Gy in Five Fractions Will Not Be Tolerated without a Hydrogel Spacer;Cancers;2024-04-11

3. Spatio-temporal modelling of phenotypic heterogeneity in tumour tissues and its impact on radiotherapy treatment;Journal of Theoretical Biology;2023-01

4. A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer;Radiation Oncology;2022-04-04

5. Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer;Scientific Reports;2022-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3